• 제목/요약/키워드: Subcutaneous injections

검색결과 66건 처리시간 0.03초

넙치(Paralichthys olivaceus)의 Streptococcus parauberis 인위감염을 위한 공격실험 방법에 관한 연구 (An Experimental Study on Artificial Infection of Olive Flounder Paralichthys olivaceus by Streptococcus parauberis Using Different Injection Sites)

  • 김태호;이남실;최혜승;정승희;한현자
    • 한국수산과학회지
    • /
    • 제53권4호
    • /
    • pp.628-636
    • /
    • 2020
  • Streptococcosis in the olive flounder Paralichthys olivaceus can be caused by Streptococcus parauberis. We compared three routes of administration for experimental injections of the S. parauberis 19FBSPa0003 strain in the olive flounder. Pathological changes were observed during the experimental infection. Inflammation of the serous membrane in the liver, intestine, spleen and heart was the major pathological change found in the infected olive flounder. No mortality was observed in fish that received intraperitoneal (IP) injection at less than 1×104 colony-forming unit (CFU)/fish. The lethal dose 50 for olive flounder, given an intravenous (IV) injection, was 7.94×104 CFU/fish. Fish with a higher concentration of IV injected S. parauberis (1×108 CFU/fish) died within a maximum of two days. However, serious necrosis and bacterial proliferation in ellipsoidal cells of the spleen and heart tissues were found in moribund or dead fish, 1-2 days after IV injection. Similar histopathological signs were observed in olive flounder inoculated by subcutaneous (SC) infected and naturally infected. In addition, SC was also strongly associated with bacteria concentration and cumulative mortality rate. Based on these results, SC is the recommended method for artificial infection by S. parauberis in the olive flounder.

Case Reports of Adipose-derived Stem Cell Therapy for Nasal Skin Necrosis after Filler Injection

  • Sung, Ha-Min;Suh, In-Suck;Lee, Hoon-Bum;Tak, Kyoung-Seok;Moon, Kyung-Min;Jung, Min-Su
    • Archives of Plastic Surgery
    • /
    • 제39권1호
    • /
    • pp.51-54
    • /
    • 2012
  • With the gradual increase of cases using fillers, cases of patients treated by non-medical professionals or inexperienced physicians resulting in complications are also increasing. We herein report 2 patients who experienced acute complications after receiving filler injections and were successfully treated with adipose-derived stem cell (ADSCs) therapy. Case 1 was a 23-year-old female patient who received a filler (Restylane) injection in her forehead, glabella, and nose by a non-medical professional. The day after her injection, inflammation was observed with a $3{\times}3cm$ skin necrosis. Case 2 was a 30-year-old woman who received a filler injection of hyaluronic acid gel (Juvederm) on her nasal dorsum and tip at a private clinic. She developed erythema and swelling in the filler-injected area A solution containing ADSCs harvested from each patient's abdominal subcutaneous tissue was injected into the lesion at the subcutaneous and dermis levels. The wounds healed without additional treatment. With continuous follow-up, both patients experienced only fine linear scars 6 months postoperatively. By using adipose-derived stem cells, we successfully treated the acute complications of skin necrosis after the filler injection, resulting in much less scarring, and more satisfactory results were achieved not only in wound healing, but also in esthetics.

DA-3030(recombinant human granulocyte colony-stimulating factor)의 정맥, 근육 또는 피하주사시 실험동물에서의 약물동력 학 및 조직 분포 (Pharmacokinetics and Tissue Distribution of DA-3030 (recombinant human granulocyte colony-stimulating factor) after Intravenous, Intramuscular or Subcutaneous Administrations to the Laboratory Animals.)

  • 이응두;심현주;이종진;이상득;강수형;김원배;양중익
    • Biomolecules & Therapeutics
    • /
    • 제2권4호
    • /
    • pp.310-315
    • /
    • 1994
  • The pharmacokinetics and tissue distribution of DA-3030 (recombinant human granulocyte colony-stimulating factor, rhG-CSF, recently manufactured by Dong-A research laboratory of Dong-A Pharmaceutical Company) were compared with reported data in the literature. After intravenous(i.v.) administration of DA-3030, at dose of 5, 10 and 100 $\mu\textrm{g}$/kg to rats, some pharmacokinetic parameters, such as terminal half-lives(1.05, 1.19 and 1.83 hr, respectively) and clearance (84.0, 54.8 and 45.5 mι/hr/kg, repectively), were dose-dependent. This could be due to the saturable metabolism of DA-3030 in rats. Similar results were also reported. After subcutaneous(s.c.) and intramuscular(i.m.) administrations of DA-3030, 10 $\mu\textrm{g}$/kg to rats, the extent of bioavailability(absolute bioavailability) were incomplete; the values were 23.3 and 18.2% after s.c. and i.m. injections, respectively, due to the degradation of DA-3030 by protease. After 7-consecutive day i.v. administrations of DA-3030, 10 $\mu\textrm{g}$/kg/day, to rats, the plasma concentrations and pharmacokinetic parameters of DA-3030 were not significantly different from those in single administration. In mice and dogs at DA-3030 dose of 10 $\mu\textrm{g}$/kg, the plasma concentrations of DA-3030 were also declined rapidly with terminal half-lives of 1.31 and 1.15 hr, respectively. DA-3030 was highly concentrated in the kidney after i.v. administration of DA-3030, 10 $\mu\textrm{g}$/kg, to rats, and the results were similar to those obtained using radiolabelled rhG-CSF in the literature. Above data indicate that DA-3030 has similar properties to rhG-CSF manufactured by other companies in view of pharmacokinetics.

  • PDF

Pharmacological and non-pharmacological strategies for preventing postherpetic neuralgia: a systematic review and network meta-analysis

  • Kim, Junhyeok;Kim, Min Kyoung;Choi, Geun Joo;Shin, Hwa Yong;Kim, Beom Gyu;Kang, Hyun
    • The Korean Journal of Pain
    • /
    • 제34권4호
    • /
    • pp.509-533
    • /
    • 2021
  • Background: Postherpetic neuralgia (PHN) is a refractory complication of herpes zoster (HZ). To prevent PHN, various strategies have been aggressively adopted. However, the efficacy of these strategies remains controversial. Therefore, we aimed to estimate the relative efficacy of various strategies used in clinical practice for preventing PHN using a network meta-analysis (NMA). Methods: We performed a systematic and comprehensive search to identify all randomized controlled trials. The primary outcome was the incidence of PHN at 3 months after acute HZ. We performed both frequentist and Bayesian NMA and used the surface under the cumulative ranking curve (SUCRA) values to rank the interventions evaluated. Results: In total, 39 studies were included in the systematic review and NMA. According to the SUCRA value, the incidence of PHN was lower in the order of continuous epidural block with local anesthetics and steroids (EPI-LSE), antiviral agents with subcutaneous injection of local anesthetics and steroids (AV + sLS), antiviral agents with intracutaenous injection of local anesthetics and steroids (AV + iLS) at 3 months after acute HZ. EPI-LSE, AV + sLS and AV + iLS were also effective in preventing PHN at 1 month after acute HZ. And paravertebral block combined with antiviral and antiepileptic agents was effective in preventing PHN at 1, 3, and 6 months. Conclusions: The continuous epidural block with local anesthetics and steroid, antiviral agents with intracutaneous or subcutaneous injection of local anesthetics and a steroid, and paravertebral block combined with antiviral and antiepileptic agents are effective in preventing PHN.

Pathophysiological Role of TLR4 in Chronic Relapsing Itch Induced by Subcutaneous Capsaicin Injection in Neonatal Rats

  • Hee Joo Kim;Eun-Hui Lee;Yoon Hee Lim;Dongil Jeong;Heung Sik Na;YunJae Jung
    • IMMUNE NETWORK
    • /
    • 제22권2호
    • /
    • pp.20.1-20.9
    • /
    • 2022
  • Despite the high prevalence of chronic dermatitis and the accompanied intractable itch, therapeutics that specifically target itching have low efficacy. Increasing evidence suggests that TLRs contribute to immune activation and neural sensitization; however, their roles in chronic itch remain elusive. Here, we show that the RBL-2H3 mast cell line expresses TLR4 and that treatment with a TLR4 antagonist opposes the LPS dependent increase in mRNA levels of Th2 and innate cytokines. The pathological role of TLR4 activation in itching was studied in neonate rats that developed chronic itch due to neuronal damage after receiving subcutaneous capsaicin injections. Treatment with a TLR4 antagonist protected these rats with chronic itch against scratching behavior and chronic dermatitis. TLR4 antagonist treatment also restored the density of cutaneous nerve fibers and inhibited the histopathological changes that are associated with mast cell activation after capsaicin injection. Additionally, the expression of IL-1β, IL-4, IL-5, IL-10, and IL-13 mRNA in the lesional skin decreased after TLR4 antagonist treatment. Based on these data, we propose that inhibiting TLR4 alleviated itch in a rat model of chronic relapsing itch, and the reduction in the itch was associated with TLR4 signaling in mast cells and nerve fibers.

한우 체지방 감소 쇠고기 생산을 위한 복강 및 피하지방 항체 개발 (Development of Polyclonal Antibodies to Abdominal and Subcutaneous Adipocytes for Fat-Reduced Hanwoo Beef Production)

  • 최창원;김유현;김성진;송만강;권응기;오영균;홍성구;최성호;백경훈
    • 한국축산식품학회지
    • /
    • 제28권5호
    • /
    • pp.651-659
    • /
    • 2008
  • 본 연구는 국내 고유종인 한우의 부위별 불가식 체지방 감소를 위한 특이 다클론 항체의 개발 및 타장기 안전성을 확인하고자 실시되었다. Collagenase digestion 방법으로 한우의 복강 및 피하지방세포 원형질막 단백질을 분리하여 면양에 3회에 걸쳐 수동면역 주사하고, 면역 주사 전 및 후에 비면역혈청과 항혈청(항체)을 생산하였다. 생산된 한우 부위별 지방 항체의 역가와 한우의 주요 장기 조직인 심장, 신장, 간장, 폐, 근육 및 비장세포의 원형질막 단백질에 대한 타장기 교차반응성과 한우의 부위별 지방 조직에서 지방세포를 분리하고 각각 배양시킨 후 개발된 한우 지방 항체를 직접 주입한 뒤 LDH 수준을 조사하였다. 복강 및 피하지방세포 원형질막 단백질들은 서로 유사하면서도 특이적인 단백질을 가지고 있는 것으로 SDS-PAGE 분석을 통해 확인할 수 있었다. 희석배율 1:1,000배를 기준으로 비 면역혈청은 항원-항체 결합 반응이 거의 측정되지 않았으나, 복강 및 피하지방 항체는 희석배율 1:128,000배 및 1:64,000배까지 각각 항원-항체 반응이 감지되었으며, 이는 본 연구에서 생산한 부위별 지방 특이 다클론 항체가 지방세포 원형질막 단백질에 대해 매우 강한 역가를 가진 항체임을 시사한다. 또한 복강 및 피하지방 항체는 타 장기들과는 특이한 반응을 나타내지 않았다. 본 연구에서 개발한 두 항체들은 모두 항원으로 이용된 부위의 지방세포 원형질막 단백질과 가장 높은 반응을 나타내었으며, 복강 및 피하지방특이항체는 비 면역혈청에 비해 유의적으로 높은 세포독성 효과가 있음을 확인할 수 있었다. 이상의 결과를 종합할 때 본 연구에서 개발된 복강 및 피하 지방 감소 다클론 항체는 높은 역가, 타 장기 안전성 및 세포 파괴 효과가 있었으며 생체 타장기 안전성 등 향 후 기존의 전체 지방에서 생산한 항체의 단점을 보완할 수 있는 연구가 지속될 경우 불가식 체지방이 감소된 저지방 한우 고급육 생산이 가능하리라고 사료된다.

질벽의 실리콘 액 주사에 의한 폐색전종 및 급성 호흡곤란 증후군 1예 (A Case of Acute Respiratory Distress Syndrome with Pulmonary Embolism Induced by Injection of Silicone at Vaginal Wall)

  • 강문보;김성태;이정구;서찬종;이화은;정종배;김성권;김철;박정웅;정성환;남귀현
    • Tuberculosis and Respiratory Diseases
    • /
    • 제46권3호
    • /
    • pp.414-419
    • /
    • 1999
  • 실리콘 액은 미용 및 성형수술에 널리 사용되어지고 실리콘에 의한 불법적인 의료행위가 증가함에 따라 국소적 부작용 뿐만 아니라 폐 색전증에 의한 급성 호흡곤란 증후군등의 치명적인 폐침범의 부작용을 일으킨다는 보고가 있으나 국내보고는 아직 없었다. 본 증례에서는 건강한 39세 젊은 여자 환자가 질벽에 실리콘액을 주사한 후에 발생한 폐 색전증을 동반한 급성 호흡곤란 증후군 1예을 경험하였기에 문헌고찰과 함께 보고하는 바이다.

  • PDF

Antinociceptive Effects of Prim-O-Glucosylcimifugin in Inflammatory Nociception via Reducing Spinal COX-2

  • Wu, Liu-Qing;Li, Yu;Li, Yuan-Yan;Xu, Shi-hao;Yang, Zong-Yong;Lin, Zheng;Li, Jun
    • Biomolecules & Therapeutics
    • /
    • 제24권4호
    • /
    • pp.418-425
    • /
    • 2016
  • We measured anti-nociceptive activity of prim-o-glucosylcimifugin (POG), a molecule from Saposhnikovia divaricate (Turcz) Schischk. Anti-nociceptive or anti-inflammatory effects of POG on a formalin-induced tonic nociceptive response and a complete Freund's adjuvant (CFA) inoculation-induced rat arthritis pain model were studied. Single subcutaneous injections of POG produced potent anti-nociception in both models that was comparable to indomethacin analgesia. Anti-nociceptive activity of POG was dose-dependent, maximally reducing pain 56.6% with an $ED_{50}$ of 1.6 mg. Rats given POG over time did not develop tolerance. POG also time-dependently reduced serum TNF${\alpha}$, IL-$1{\beta}$ and IL-6 in arthritic rats and both POG and indomethacin reduced spinal prostaglandin E2 ($PGE_2$). Like indomethacin which inhibits cyclooxygenase-2 (COX-2) activity, POG dose-dependently decreased spinal COX-2 content in arthritic rats. Additionally, POG, and its metabolite cimifugin, downregulated COX-2 expression in vitro. Thus, POG produced potent anti-nociception by downregulating spinal COX-2 expression.

Development of a Competitive Direct Enzyme-Linked Immunosorbent Assay for Teicoplanin

  • Lee, Hyang-Burm;Kwak, Bo-Yeon;Lee, Jae-Chan;Kim, Chang-Jin;Shon, Dong-Hwa
    • Journal of Microbiology and Biotechnology
    • /
    • 제14권3호
    • /
    • pp.612-619
    • /
    • 2004
  • A competitive direct enzyme-linked immunosorbent assay (cdELISA) was developed for selective and rapid detection of a glycopeptide antibiotic, teicoplanin (TP). TP was conjugated to bovine serum albumin (BSA) for use as an immunogen. Repeated subcutaneous injections of 0.5 mg of the conjugate was effective in generating specific polyclonal antibody (PAb) toward TP in rabbits, as determined by cdELISA. TP-horseradish peroxidase conjugate (TP-HRP) was used as an enzyme marker. The cdELISA was developed based on a competition reaction between TP-BSA PAb and TP-HRP conjugate. The TP-BSA PAb was highly sensitive (detection limit, 0.3 ng/ml and specific toward teicoplanin, showing no cross-reactivity to other glycopeptide antibiotics including vancomycin. There were good correlations ($r^2$=0.84 and 0.76, respectively) between cdELISA and microbiological assay, and high-performance liquid chromatography. The cdELISA system developed in this work is expected to be useful not only for selective and rapid monitoring of TP but also for study of TP pharmacokinetics.

랫트에서의 Gentamicin신장독성(腎臟毒性)에 관한 연구(硏究) (Studies on Gentamicin-induced Nephrotoxicity in Rats)

  • 조인수;김태종;윤화중
    • 대한수의학회지
    • /
    • 제26권1호
    • /
    • pp.125-137
    • /
    • 1986
  • Sprague-Dawley rats received subcutaneous injections of gentamicin sulfate, 50 and 100mg/kg for 3, 7 and 10 days. The hematological and blood chemical values were determined. Kidneys were examined histologically and ultrastructurally. The results obtained were summarized as follows; 1. The serum values of aspartate transaminase, blood urea nitrogen and creatinine in the rats administered gentamicin, 50 and 100mg/kg/day were significantly increased than those in the control. 2. The ratio of kidney weight to body weight was significantly increased in the rats injected gentamicin, 100mg/kg for 10 days than those in the control. 3. The brush borders of proximal convoluted tubules in the kindneys received gentamicin, 50 and 100mg/kg/day were decreased or absent in periodic acid-Schiff staining. 4. The necrosis of proximal convoluted tubules was shown in the rats given gentamicin, 50 and 100mg/kg for 7 and 10 days. 5. The regeneration of the proximal tubular epithelia was observed in the rats treated gentamicin, 100mg/kg for 10 days. 6. The number and size of lysosomes were increased in the proximal convoluted tubules of the rats injected gentamicin, 50mg/kg for 7 days, many of which contained myeloid bodies.

  • PDF